van de Kamp Minke M, Scheffers Mia, Emck Claudia, Fokker Ties J, Hatzmann Janneke, Cuijpers Pim, Beek Peter J
Faculty of Behavioural and Movement Sciences, Amsterdam Movement Sciences, Vrije Universiteit Amsterdam, the Netherlands.
School of Health, Movement & Education, Windesheim University of Applied Sciences, Zwolle, the Netherlands.
J Trauma Stress. 2023 Oct;36(5):835-848. doi: 10.1002/jts.22968. Epub 2023 Sep 13.
This study is an update of the meta-analysis we published in 2019 on the effectiveness of body- and movement-oriented interventions (BMOIs) for adults with posttraumatic stress disorder (PTSD) in decreasing PTSD symptoms and secondary outcomes of depressive symptoms, sleep disturbance, and interoceptive awareness. Search terms for BMOIs and PTSD were combined to identify eligible studies in four bibliographical databases. Articles were selected if they included adult participants with a primary diagnosis of PTSD, included BMOI as one of the investigated therapies, were designed as a comparative outcome trial with any control condition, and involved a standardized outcome measure for PTSD symptom severity. This resulted in the addition of 14 new studies compared to the 2019 study. The meta-analysis, which included 29 studies in total, resulted in a mean Hedges' g effect size of 0.50, 95% CI [0.22, 0.79], in decreasing PTSD symptoms, with very high heterogeneity, I = 89%. Meta-analyses of secondary outcomes resulted in Hedges' g effect sizes of 0.37, 95% CI [0.08, 0.66] for depressive symptoms; 0.62, 95% CI [0.42, 0.81] for sleep quality; and -0.10, 95% CI [-0.23, 0.43] for interoceptive awareness. The risk of bias analysis resulted in some concerns or high risk of bias in almost all included studies; only one study had a low risk of bias. We conclude that BMOIs may be valuable for patients with PTSD. There is, however, still a lack of high-quality studies with proper control conditions and long-term follow-up periods from which to draw conclusions.
本研究是我们于2019年发表的关于以身体和运动为导向的干预措施（BMOIs）对创伤后应激障碍（PTSD）成人患者减轻PTSD症状以及抑郁症状、睡眠障碍和内感受性觉知等次要结局有效性的荟萃分析的更新。将BMOIs和PTSD的检索词合并，以在四个文献数据库中识别符合条件的研究。如果文章纳入了原发性诊断为PTSD的成年参与者，将BMOI作为所研究的治疗方法之一，设计为有任何对照条件的比较结局试验，并涉及PTSD症状严重程度的标准化结局测量，则将其纳入。与2019年的研究相比，这导致新增了14项研究。该荟萃分析总共纳入了29项研究，结果显示在减轻PTSD症状方面，平均Hedges' g效应量为0.50，95%置信区间[0.22, 0.79]，异质性非常高，I² = 89%。次要结局的荟萃分析结果显示，抑郁症状的Hedges' g效应量为0.37，95%置信区间[0.08, 0.66]；睡眠质量的为0.62，95%置信区间[0.42, 0.81]；内感受性觉知的为 -0.10，95%置信区间[-0.23, 0.43]。偏倚风险分析表明，几乎所有纳入的研究都存在一些担忧或高偏倚风险；只有一项研究的偏倚风险较低。我们得出结论，BMOIs可能对PTSD患者有价值。然而，仍然缺乏高质量的研究，这些研究需要有适当的对照条件和长期随访期才能得出结论。
